Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy

Author： Parmiani Giorgio Maccalli Cristina Maio Michele

Publisher： MDPI

E-ISSN： 2076-393x|3|2|420-428

ISSN： 2076-393x

Source： Vaccines, Vol.3, Iss.2, 2015-05, pp. : 420-428

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma

By Ahn Brian J. Pollack Ian F. Okada Hideho

Cancers, Vol. 5, Iss. 4, 2013-11 ,pp. : 1379-1412

MDPI

Access to resources Recommend Favorite

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade

By Marchini Antonio Scott Eleanor M. Rommelaere Jean

Viruses, Vol. 8, Iss. 1, 2016-01 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T

By Yoon Dok Hyun Osborn Mark J. Tolar Jakub Kim Chong Jai

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 340-340

MDPI

Access to resources Recommend Favorite

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”

By Gelao Lucia Criscitiello Carmen Esposito Angela Goldhirsch Aron Curigliano Giuseppe

Toxins, Vol. 6, Iss. 3, 2014-03 ,pp. : 914-933

MDPI

Access to resources Recommend Favorite

A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway Translational Blockade of Immune Checkpoints

By Li Yongshu Li Fangfei Jiang Feng Lv Xiaoqing Zhang Rongjiang Lu Aiping Zhang Ge

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1151-1151

MDPI

Access to resources Recommend Favorite